B7MGG6 ATPase RavA MolNFT, Molecular NFT on GenesisL1

ATPase RavA

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeibe2cehdqqvzjv2va3k2cszcwar3qhbihzd2m6jfuxld4poaetj2m/metadata.json

IPFS of structure file:

bafybeia7moslxhyicyt56i6poexiwsbzenmdojpohs5yj6ufomkt6m5pam/AF-B7MGG6-F1-model_v2.pdb

First NFT owner address (eip-55):

0x8DA6C6750089f15EC3259e560D5B158356F5Ab08

First NFT owner address (bech32):

genesis13knvvagq38c4ase9netq6kc4sdt0t2cgcwcnuz

Current NFT ID #332896 owner (web3):

0xaF0Dee25ddf5E46fC5F06F9c967adD3be668e3c6

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
332896
Accession (UniProt):
B7MGG6
Name::
ATPase RavA
Experimental Method:
Predicted structure
Sequence source:
ESCHERICHIA COLI O45:K1 (STRAIN S88 / EXPEC)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B7MGG6 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B7MGG6|RAVA_ECO45 ATPase RavA OS=Escherichia coli O45:K1 (strain S88 / ExPEC) OX=585035 GN=ravA PE=3 SV=1 MAHPHLLAERISRLSSSLEKGLYERSHAIRLCLLAALSGESVFLLGPPGIAKSLIARRLKFAFQNARAFEYLMTRFSTPEEVFGPLSIQALKDEGRYERLTSGYLPEAEIVFLDEIWKAGPAILNTLLTAINERQFRNGALVEKIPMRLLVAASNELPEADSSLEALYDRMLIRLWLDKVQDKANFRSMLTSQQDENDNPVPASLQITDEEYERWQKEIGEITLPDHVFELIFMLRQQLDKLPDAPYVSDRRWKKAIRLLQASAFFSGRSAVAPVDLILLKDCLWYDAQSLNLIQQQIDVLMTGHAWQQQGMLTRLGAIVQRHLQLQQQQSDKTALTVIRLGGIFSRRQQYQLPVNVTASTLTLLLQKPLKLHDMEVVHISFERSALEQWLSKGGEIRGKLNGIGFAQKLNLEVDSAQHLVVRDVSLQGSTLALPGSSAEGLPGEIKQQLEELESDWRKQHALFSEQQKCLFIPGDWLGRIEASLQDVGAQIRQAQQC

B7MGG6 AF NFT

MOLNFT AF v1

NFT data

MOLNFT B7MGG6 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience